E. Ogusa

发表

Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study

H. Nakajima, Kenji Matsumoto, Y. Nakajima, 2018, Clinical lymphoma, myeloma & leukemia.

R‐CHOP therapy alone in limited stage diffuse large B‐cell lymphoma

Y. Ishigatsubo, E. Yamazaki, K. Fujimaki, 2013, British journal of haematology.

Clinical Significance of Pulmonary Function Tests in Long-Term Survivors after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2013 .

Successful azacitidine treatment with increase of regulatory T cells for relapsed acute myeloid leukemia after allogeneic stem cell transplant

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2013, Leukemia & lymphoma.

Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type

Y. Ishigatsubo, E. Yamazaki, K. Fujimaki, 2014, Medical Oncology.

Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia

Y. Ishigatsubo, E. Yamazaki, Kenji Matsumoto, 2017, Leukemia & lymphoma.

Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Y. Ishigatsubo, K. Fujimaki, S. Fujisawa, 2013, Leukemia research.

Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue in Japanese population

Y. Ishigatsubo, N. Tomita, Y. Hattori, 2013, Hematological oncology.

Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.

Y. Ishigatsubo, K. Fujimaki, S. Fujisawa, 2013, Journal of clinical and experimental hematopathology : JCEH.

Impact of pretransplant serum ferritin on outcome in adult patients receiving cord blood transplant for acute leukemia

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2014, Leukemia & lymphoma.

Prognostic index for relapsed acute leukemia after allogeneic stem cell transplant

Y. Ishigatsubo, Kenji Matsumoto, H. Kanamori, 2014, Leukemia & lymphoma.

Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation.

H. Nakajima, Kenji Matsumoto, H. Kanamori, 2020, Blood advances.

Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2014, Leukemia & lymphoma.

Recovery of natural killer cells and prognosis after cord blood transplantation.

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2013, Leukemia research.

Clinical features of extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue

Y. Ishigatsubo, N. Tomita, Y. Hattori, 2012, Hematological oncology.

Retrospective Study of Incidence and Prognostic Significance of Eosinophilia after Allogeneic Hematopoietic Stem Cell Transplantation: Influence of Corticosteroid Therapy

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2016, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Predictive value of risk assessment scores in patients with hematologic malignancies undergoing reduced‐intensity conditioning allogeneic stem cell transplantation

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2014, American journal of hematology.

Prognostic Impact of Delayed Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy

H. Nakajima, H. Kanamori, Masatsugu Tanaka, 2016 .

Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation

H. Nakajima, Kenji Matsumoto, S. Fujisawa, 2017, Leukemia & lymphoma.

Body mass index is a prognostic factor in adult patients with acute myeloid leukemia

E. Yamazaki, H. Nakajima, Kenji Matsumoto, 2017, International Journal of Hematology.

Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

E. Yamazaki, H. Nakajima, Kenji Matsumoto, 2020, International Journal of Hematology.

Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia

E. Yamazaki, H. Nakajima, Kenji Matsumoto, 2019, International Journal of Hematology.

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

E. Yamazaki, H. Nakajima, Kenji Matsumoto, 2017 .

Clinical features of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Y. Ishigatsubo, N. Tomita, Y. Hattori, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of the Order of Administration of Total Body Irradiation and Cyclophosphamide on the Outcome of Allogeneic Hematopoietic Cell Transplantation

S. Kako, M. Onizuka, Satoshi Takahashi, 2014 .

Identification of Bone Marrow Involvement of FL: Comparison of PET-CT and Bone Marrow Biopsy.

H. Nakajima, Kenji Matsumoto, Y. Nakajima, 2016 .

Human herpesvirus‐6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen

Y. Ishigatsubo, Kenji Matsumoto, A. Maruta, 2014, Clinical transplantation.

Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.

Y. Nakajima, H. Kanamori, Masatsugu Tanaka, 2024, Cytotherapy.